- Home
- DNTH vs GBX Comparison
DNTH vs GBX Comparison
Compare DNTH & GBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- GBX
- Stock Information
- Founded
- DNTH 2015
- GBX 1974
- Country
- DNTH United States
- GBX United States
- Employees
- DNTH N/A
- GBX N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- GBX Railroads
- Sector
- DNTH Health Care
- GBX Industrials
- Exchange
- DNTH Nasdaq
- GBX Nasdaq
- Market Cap
- DNTH 1.4B
- GBX 1.5B
- IPO Year
- DNTH N/A
- GBX N/A
- Fundamental
- Price
- DNTH $33.73
- GBX $42.60
- Analyst Decision
- DNTH Strong Buy
- GBX Hold
- Analyst Count
- DNTH 11
- GBX 2
- Target Price
- DNTH $65.22
- GBX $57.00
- AVG Volume (30 Days)
- DNTH 503.3K
- GBX 383.0K
- Earning Date
- DNTH 11-05-2025
- GBX 10-28-2025
- Dividend Yield
- DNTH N/A
- GBX 3.00%
- EPS Growth
- DNTH N/A
- GBX 27.96
- EPS
- DNTH N/A
- GBX 6.35
- Revenue
- DNTH $4,854,000.00
- GBX $3,240,200,000.00
- Revenue This Year
- DNTH N/A
- GBX N/A
- Revenue Next Year
- DNTH N/A
- GBX N/A
- P/E Ratio
- DNTH N/A
- GBX $6.71
- Revenue Growth
- DNTH 17.87
- GBX N/A
- 52 Week Low
- DNTH $13.37
- GBX $37.77
- 52 Week High
- DNTH $40.16
- GBX $71.06
- Technical
- Relative Strength Index (RSI)
- DNTH 47.36
- GBX 38.79
- Support Level
- DNTH $32.28
- GBX $40.93
- Resistance Level
- DNTH $35.40
- GBX $46.33
- Average True Range (ATR)
- DNTH 1.62
- GBX 1.27
- MACD
- DNTH -0.20
- GBX -0.32
- Stochastic Oscillator
- DNTH 27.78
- GBX 53.32
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About GBX Greenbrier Companies Inc. (The)
Greenbrier Companies Inc designs, manufactures, and markets railroad freight car equipment in North America and Europe, marine barges in North America and provides wheel services, railcar refurbishment, and parts, leasing and other services to the railroad. Its segments include Manufacturing, Maintenance Services and Leasing & Management Services. The company generates a majority of its revenue from the manufacturing segment. Geographically, it derives a majority of its revenue from the United States.